Dreigende wereldwijde tekorten aan antibiotica, reports the NRC

Daan van Lent covers the Foundation’s latest white paper, about antibiotic supply chains, for Dutch national newspaper the NRC. He zeroes in on how pharmaceutical companies are leaving the antibiotics market due to low prices, putting the world at increasing risk of shortages.

“Grote wereldwijde tekorten aan antibiotica dreigen, omdat grote farmaceutische bedrijven zich terugtrekken uit de productie vanwege de lage prijzen. De aanlevering van de middelen tegen ziekmakende bacteriën is veel te kwetsbaar geworden.” Writing in the NRC, Daan van Lent covers the latest white paper published by the Access to Medicine Foundation. He puts the spotlight on the economic factors that are causing the antibiotics market to fail. The white paper is titled “Shortages, stockouts and scarcity: the issues facing the security of antibiotic supply and the role for pharmaceutical companies”.